Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.
about
Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody ResponsesSubtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle propertiesMetronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancerNanoways to overcome docetaxel resistance in prostate cancer.Future of the particle replication in nonwetting templates (PRINT) technologyPRINT: a novel platform toward shape and size specific nanoparticle theranostics.Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.Rapidly-dissolvable microneedle patches via a highly scalable and reproducible soft lithography approach.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.More effective nanomedicines through particle designEvaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle.Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.Scalable imprinting of shape-specific polymeric nanocarriers using a release layer of switchable water solubilityReductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing.Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancerEffect of aspect ratio and deformability on nanoparticle extravasation through nanopores.Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation.Engineering nanomedicines using stimuli-responsive biomaterials.Nanomedicine in chemoradiation.Generating Better Medicines for Cancer.Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray.Advances in drug delivery via electrospun and electrosprayed nanomaterialsNanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacyRNA replicon delivery via lipid-complexed PRINT protein particles.Docetaxel nanotechnology in anticancer therapy.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Emerging applications of phase-change materials (PCMs): teaching an old dog new tricks.Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.Materials and methods for delivery of biological drugs.From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.PLGA: the smart therapeutics goods carrier.Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.Cell membrane coated nanoparticles: next-generation therapeutics.“Smart” Surface Capsules for Delivery DevicesElaborate Design Strategies Toward Novel Microcarriers for Controlled Encapsulation and ReleaseNanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype
P2860
Q27493140-5723DD49-8EEF-41D5-858B-85F9D51AE12AQ30744724-FA0193D0-836B-4941-A9B7-31DFFFCF9821Q33875597-6CF181FC-E007-4AD3-B8BC-07F82EF7293BQ33909084-7AD67E0B-FBA2-4B23-87BE-DDC1F3798BFBQ34149094-FB057E23-0465-4BE1-954B-2C9BB3EDF203Q34149121-CF7962B0-FBE2-4A4F-BE41-F23BCC84D35EQ34316088-74DBF810-8A37-4E3B-8816-1C576A154CE7Q34671534-C3E7E4DC-3A17-404D-82C7-D6EAE9064BE3Q34675068-09AAAEE3-7B28-4FB9-9BA6-9F1F9AAC4D2AQ35106115-AFE8E93A-7F74-437A-AE1F-5893C98F1CDAQ35551143-1AE30E4C-951A-41B5-B1F2-429FFA7BAA18Q35801327-D8CEF392-07F2-49D6-B7FE-C65BBEB9DD58Q35856885-2BED98BE-C056-4686-8278-940F0F62CB15Q35975665-ABD5546A-BCEE-4A73-B897-429574671345Q35982462-F12D33D5-954A-4319-9DCE-6D3F5E40DD64Q36028372-E120911E-C1B9-443E-85A8-9537C4758DDFQ36132897-031A01F8-C5E7-4B96-AE6E-72CAD245E4ADQ36174884-EA54F445-062B-45F9-A60A-2FDB59DF7025Q36838995-A841563B-AC04-431A-B5CA-94AB91589FBAQ36922604-B1D55CA4-A8EC-4180-B1C6-15FAE5F2BC9EQ37007729-9889B9EF-8C51-486C-89A9-E8DF2D3EC9C9Q37103471-69B0C6E8-9E1D-4878-AA2A-B73E83D1CA09Q37253857-3DDBE39F-5AB5-4773-9D70-C3F054F74F2FQ37628162-23E3035B-CA90-4A25-9A63-0186FBC4D76BQ38003964-3F847A58-2861-423B-9D7B-CD6124EDCB19Q38150118-7574A6D6-75CA-4988-A3A9-BD967124DC51Q38182510-593A4949-BF5E-4695-8AE0-91CEB9000085Q38261278-6C08123F-003A-4E1C-AFAF-F781DC812E32Q38865261-B69F7BDE-51F2-418C-9817-31838BD71279Q38987392-AAF4EEDC-180E-4916-A546-F275FE502DA3Q39060269-8D78AAE7-B7B7-43E9-AA43-0E2BEECB21FFQ39325848-9FD4567E-136E-4C75-BBCD-DABD81CF9838Q41280444-CF9B9F8B-8278-41A9-A860-CA46BDE29CC5Q41545490-2616B793-BCF4-4AF5-9659-B5CB631F383BQ42237070-0C216FA6-F0BD-465C-B4AF-C41C4F6DF2CDQ47613637-EC5B092B-C94F-4F20-9B3E-A2EC7F02E750Q57341622-07DD41A2-366B-46A1-929F-D45E85F9216CQ58344054-92E74462-FF1D-4E78-9CBD-956A5A52F14BQ58699988-0EC1D968-C3C3-4D64-A852-B12BD8662796
P2860
Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@ast
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@en
type
label
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@ast
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@en
prefLabel
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@ast
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@en
P2093
P2860
P356
P1433
P1476
Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.
@en
P2093
Elizabeth M Enlow
J Christopher Luft
Joseph M DeSimone
Mary E Napier
P2860
P304
P356
10.1021/NL104117P
P407
P577
2011-01-25T00:00:00Z